Bank of Montreal Can raised its position in shares of Addus HomeCare Co. ( NASDAQ:ADUS – Free Report ) by 17.4% in the fourth quarter, according to the company in its most recent filing with the SEC.
The institutional investor owned 2,493 shares of the company’s stock after purchasing an additional 369 shares during the quarter. Bank of Montreal Can’s holdings in Addus HomeCare were worth $312,000 at the end of the most recent quarter. Several other large investors have also bought and sold shares of ADUS.
JPMorgan Chase & Co. increased its position in shares of Addus HomeCare by 10.2% during the third quarter.
JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock valued at $24,371,000 after acquiring an additional 16,997 shares in the last quarter. Principal Financial Group Inc.
increased its holdings in shares of Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc.
now owns 505,853 shares of the company’s stock worth $67,293,000 after purchasing an additional 75,409 shares in the last quarter. Cherry Creek Investment Advisors Inc. purchased a new position in shares of Addus HomeCare in the fourth quarter worth $340,000.
Amundi lifted its holdings in shares of Addus HomeCare by 185.9% during the fourth quarter. Amundi now owns 9,008 shares of the company’s stock valued at $1,139,000 after purchasing an additional 5,857 shares in the last quarter.
Finally, Barclays PLC boosted its position in shares of Addus HomeCare by 204.8% during the third quarter. Barclays PLC now owns 43,470 shares of the company’s stock valued at $5,783,000 after buying an additional 29,207 shares during the last quarter.
95.35% of the stock is owned by hedge funds and other institutional investors. Analyst Ratings Changes A number of analysts have recently issued reports on ADUS shares.
JMP Securities reaffirmed a “market outperform” rating and set a $150.00 price target on shares of Addus HomeCare in a report on Tuesday. Stephens reissued an “overweight” rating and set a $142.
00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th.
Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, January 24th.
Finally, Macquarie restated an “outperform” rating and set a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. One analyst has rated the stock with a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company.
According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $139.00. Addus HomeCare Stock Up 0.
8 % Shares of NASDAQ:ADUS opened at $98.86 on Thursday. The company has a market capitalization of $1.
80 billion, a price-to-earnings ratio of 22.62, a price-to-earnings-growth ratio of 1.41 and a beta of 0.
93. Addus HomeCare Co. has a 52 week low of $88.
96 and a 52 week high of $136.72. The firm has a 50 day moving average of $98.
47 and a 200 day moving average of $116.52. Addus HomeCare ( NASDAQ:ADUS – Get Free Report ) last released its quarterly earnings results on Monday, February 24th.
The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.
09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.
50%. The firm had revenue of $297.14 million during the quarter, compared to analysts’ expectations of $291.
04 million. On average, sell-side analysts expect that Addus HomeCare Co. will post 4.
59 EPS for the current year. Addus HomeCare Company Profile ( Free Report ) Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. ( NASDAQ:ADUS – Free Report ).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter ..
Business
Bank of Montreal Can Buys 369 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Bank of Montreal Can raised its position in shares of Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 17.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,493 shares of the company’s stock after purchasing an additional 369 shares during the quarter. Bank [...]